| 臺大學術典藏 |
2022-07-21T06:02:23Z |
High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines
|
Chen, Chieh-Hsin; Chou, Yi-Ting; YA-WEN YANG; Lo, Kai-Yin |
| 國立臺灣大學 |
2015 |
High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
|
Yang, Jyh-Chin; Lin, Chun-Jung; Wang, Hong-Long; Chen, Jin-De; Kao, John Y.; Shun, Chia-Tung; Lu, Chien-Wei; Lin, Bor-Ru; Shieh, Ming-Jium; Chang, Ming-Chu; Chang, Yu-Ting; Wei, Shu-Chen; Lin, Lin-Chih; Yeh, Wen-Chun; Kuo, Jen-Shin; Tung, Chien-Chih; Leong, Yew-Loong; Wang, Teh-Hong; Wong, Jau-Min; 王德宏; 謝銘鈞; 董建志; 楊智欽; 翁昭旼; 章明珠; 魏淑?; 張毓廷; 孫家棟; 林伯儒; 林君榮 |
| 臺大學術典藏 |
2020-08-07T01:43:05Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lu C.-W.; Shun C.-T.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Leong Y.-L.; Wang T.-H.; Wong J.-M.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; CHIEN-CHIH TUNG |
| 臺大學術典藏 |
2020-10-14T07:24:41Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Wang T.-H.; Tung C.-C.; Leong Y.-L.; Kuo J.-S.; Yeh W.-C.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI; Lin L.-C.; Wong J.-M. |
| 臺大學術典藏 |
2021-06-15T03:12:06Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2022-03-04T08:22:45Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-02-02T08:29:45Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; BOR-RU LIN; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-03-05T06:07:21Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; MING-CHU CHANG; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-03-18T02:02:41Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.;Lin C.-J.;Wang H.-L.;Chen J.-D.;Kao J.Y.;Chia-Tung Shun;Lu C.-W.;Lin B.-R.;Shieh M.-J.;Chang M.-C.;Chang Y.-T.;Wei S.-C.;Lin L.-C.;Yeh W.-C.;Kuo J.-S.;Tung C.-C.;Leong Y.-L.;Wang T.-H.;Wong J.-M.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; CHIA-TUNG SHUN; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2020-02-27T06:39:29Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.;Lin C.-J.;Wang H.-L.;Chen J.-D.;Kao J.Y.;Shun C.-T.;Lu C.-W.;Lin B.-R.;Ming-Jium Shieh;Chang M.-C.;Chang Y.-T.;Wei S.-C.;Lin L.-C.;Yeh W.-C.;Kuo J.-S.;Tung C.-C.;Leong Y.-L.;Wang T.-H.;Wong J.-M.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; MING-JIUM SHIEH; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
